+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nexplanon"

Women's Health Market Report 2024-2034 - Product Thumbnail Image

Women's Health Market Report 2024-2034

  • Report
  • March 2024
  • 351 Pages
  • Global
From
From
From
Endometriosis Treatment Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Endometriosis Treatment Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 143 Pages
  • Global
From
From
Nexplanon - API Insight, 2022 - Product Thumbnail Image

Nexplanon - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Nexplanon- Drug Insight, 2019 - Product Thumbnail Image

Nexplanon- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Nexplanon is a long-acting, reversible contraceptive (LARC) device used to prevent pregnancy. It is a small, thin, and flexible rod that is inserted under the skin of the upper arm and releases a low dose of progestin over a three-year period. It is a popular form of contraception among women due to its convenience and effectiveness. It is also a safe and reliable form of contraception, with few side effects. Nexplanon is available in many countries around the world, and is marketed by a number of pharmaceutical companies. It is often prescribed by healthcare providers as an alternative to other forms of contraception, such as the birth control pill. It is also used by women who are unable to take the pill due to medical conditions or lifestyle choices. The Nexplanon market is an important part of the Women's Health industry, providing a safe and reliable form of contraception for women. Companies in the market include Merck, Bayer, and Teva Pharmaceuticals. Show Less Read more